US Stock MarketDetailed Quotes

KPRX Kiora Pharmaceuticals

Watchlist
  • 3.5700
  • +0.1217+3.53%
Close Nov 27 16:00 ET
  • 3.7000
  • +0.1300+3.64%
Post 20:01 ET
10.71MMarket Cap3.40P/E (TTM)

Kiora Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kiora Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 500.000K--
--2024/Q30.000 / 7.000K--
--2024/Q20.000 / 0.000--
--2024/Q116.000M / 8.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 500.000K--
--2024/Q30.000 / 7.000K--
--2024/Q20.000 / 0.000--
--2024/Q116.000M / 8.000M--

Unlock Free Earnings Estimates

Kiora Pharmaceuticals Earnings Reports

  • 8-K: Kiora Pharmaceuticals Reports Third Quarter Results; Retinal Disease Pipeline Advancing Two Phase 2 Studies

    Nov 8 20:05

  • 10-Q: Q3 2024 Earnings Report

    Nov 8 20:05

  • 8-K: Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies

    Aug 9 19:07

  • 10-Q: Q2 2024 Earnings Report

    Aug 9 19:02

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data